Attached files
| file | filename |
|---|---|
| EX-31.3 - EX-31.3 - Horizon Therapeutics Public Ltd Co | d377168dex313.htm |
| EX-10.68 - EX-10.68 - Horizon Therapeutics Public Ltd Co | d377168dex1068.htm |
| EX-10.62 - EX-10.62 - Horizon Therapeutics Public Ltd Co | d377168dex1062.htm |
| EX-10.61 - EX-10.61 - Horizon Therapeutics Public Ltd Co | d377168dex1061.htm |
| EX-2.4 - EX-2.4 - Horizon Therapeutics Public Ltd Co | d377168dex24.htm |
| 10-K/A - FORM 10-K/A - Horizon Therapeutics Public Ltd Co | d377168d10ka.htm |
Exhibit 31.4
Certification of Principal Financial Officer
I, Paul W. Hoelscher, certify that:
| 1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Horizon Pharma plc; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: May 26, 2017
| /s/ Paul W. Hoelscher |
||
| Paul W. Hoelscher |
||
| Executive Vice President, Chief Financial Officer |
||
| (Principal Financial Officer) |